During the past decade, Hospital Universitari Vall d'Hebron; Servicio de Hematologia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 7 clinical trials were completed, i.e. on average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia" are "Non-Hodgkin's Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Lymphocytic Leukemia, Chronic" (2 trials), "Sickle Cell Disease" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia" in a lesser frequency.

Most popular intervention types in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia" are "Drug" (20 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Obinutuzumab" (9 trials), "Tocilizumab" (9 trials), "Cyclophosphamide" (5 trials), "Glofitamab" (5 trials) and "Rituximab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universitari Vall d'Hebron; Servicio de Hematologia". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hospital Universitari Vall d'Hebron; Servicio de Hematologia, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitari Vall d'Hebron; Servicio de Hematologia, 11 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".